Velbeth Elizabeth Recinos Martínez

Velbeth Elizabeth Recinos Martínez

Auto-generated profile, based on publicly available information

Velbeth Elizabeth Recinos Martínez

Universidad de San Carlos de Guatemala

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ACAna Clemente
Ana Clemente
MIMaria Gabriela Cueva Indacochea
Maria Gabriela Cueva Indacochea
VMVelbeth Elizabeth Recinos Martínez
Velbeth Elizabeth Recinos Martínez
MMMartín Eduardo Azúa Martínez
Martín Eduardo Azúa Martínez
CGCruz Vargas Katherine Gisela
Cruz Vargas Katherine Gisela
AOAshley Denisse Ayala Ochoa
Ashley Denisse Ayala Ochoa
Hidden hearing loss (HHL) has emerged as an important topic in auditory medicine because many individuals experience significant communication difficulties despite presenting normal pure-tone audiometric thresholds. This review critically analyzes current international evidence regarding the epidemiology, pathophysiology, clinical manifestations, diagnostic challenges, and therapeutic perspectives associated with HHL, with particular emphasis on cochlear synaptopathy and its implications for clinical practice. A narrative literature review was conducted using the Scientific Method as the methodological framework. Scientific publications indexed in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar were reviewed, prioritizing original investigations, systematic reviews, meta-analyses, and clinical guidelines published in peer-reviewed journals. The evidence indicates that speech-in-noise perception deficits, tinnitus, listening fatigue, and temporal auditory processing impairments represent the most frequently reported manifestations among individuals with suspected HHL. Occupational and recreational noise exposure, together with physiological aging, were consistently identified as the principal risk factors. Although conventional pure-tone audiometry remains essential for hearing assessment, it demonstrates limited sensitivity for detecting early neural dysfunction. Complementary evaluations, including speech-in-noise testing, auditory brainstem responses, extended high-frequency audiometry, and other electrophysiological techniques, provide additional diagnostic information; however, no single method currently constitutes a definitive diagnostic standard. The reviewed literature supports the implementation of multimodal diagnostic strategies integrating behavioral, physiological, and clinical findings. Furthermore, the analysis highlights the need for standardized diagnostic criteria, objective biomarkers, multicenter investigations, and increased scientific participation from Latin America. Hidden hearing loss represents an evolving multidisciplinary concept that expands the understanding of auditory dysfunction beyond conventional audiometry and emphasizes the importance of comprehensive patient-centered evaluation to improve early recognition, clinical management, and future research.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
ASAna Camila Subia Sandoval
Ana Camila Subia Sandoval
AHAlberto Escamilla Huerta
Alberto Escamilla Huerta
OMOscar Emmanuel Garcia Moreno
Oscar Emmanuel Garcia Moreno
JCJavier Emanuel Camacho-Patiño
Javier Emanuel Camacho-Patiño
VMVelbeth Elizabeth Recinos Martínez
Velbeth Elizabeth Recinos Martínez
AMAlvaro Enrique Marroquin Murcia
Alvaro Enrique Marroquin Murcia
Severe cutaneous adverse drug reactions represent a major clinical challenge due to their complex immunological mechanisms, heterogeneous manifestations, and potential to cause life-threatening systemic complications. This narrative review examines the immunopathogenesis, early recognition, diagnostic assessment, and therapeutic management of drug reaction with eosinophilia and systemic symptoms (DRESS) and Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN). Twenty scientific publications, including clinical investigations, systematic reviews, and international consensus recommendations, were analyzed through a qualitative synthesis incorporating contributions from Latin America. The findings revealed distinct patterns of immune-mediated injury, characterized by systemic inflammation, T-cell activation, and potential herpesvirus reactivation in DRESS, compared with cytotoxic keratinocyte destruction mediated by granulysin and other inflammatory pathways in SJS/TEN. Clinical evidence emphasized the relevance of early drug withdrawal, multidisciplinary assessment, and standardized instruments, including RegiSCAR, ALDEN, and SCORTEN. Therapeutic investigations identified potentially favorable outcomes associated with selected immunomodulatory interventions, including systemic corticosteroids, cyclosporine, and tumor necrosis factor-alpha inhibitors; however, methodological heterogeneity and limited randomized evidence restrict definitive conclusions regarding comparative effectiveness. Latin American contributions highlighted the importance of regional clinical guidelines and improved access to specialized care. Overall, integrating immunological knowledge with structured clinical assessment and evidence-based management may contribute to earlier recognition and more individualized care. Further multicenter investigations are required to clarify therapeutic effectiveness, identify reliable biomarkers, and improve long-term outcomes.

28 December 2025 in International Science Journal
Verified
Journal Article
Closed access
CPChristian Yael Fonseca Pérez
Christian Yael Fonseca Pérez
AVAbigail Berenice Gómez Valenzuela
Abigail Berenice Gómez Valenzuela
AVAdriana María Loor Vélez
Adriana María Loor Vélez
SCSantiago Ramírez Calderon
Santiago Ramírez Calderon
JVJorge Romeo Neri Vázquez
Jorge Romeo Neri Vázquez
VMVelbeth Elizabeth Recinos Martínez
Velbeth Elizabeth Recinos Martínez
Tissue bioengineering and regenerative aesthetic medicine have emerged as rapidly evolving interdisciplinary fields that integrate plastic surgery, regenerative medicine, endocrinology, molecular biology, biomaterials science, and biomedical engineering to promote tissue restoration and functional recovery. The objective of this review was to analyze current advances in regenerative technologies and their applications in aesthetic and reconstructive medicine. A comprehensive review of scientific literature indexed in major biomedical databases was conducted, focusing on stem cell therapies, platelet-rich plasma, extracellular vesicles, bioactive scaffolds, biomaterials, and three-dimensional bioprinting. The analyzed evidence demonstrated that adipose-derived stem cells and platelet-rich plasma remain the most established regenerative interventions due to their favorable safety profiles, accessibility, and demonstrated effectiveness in tissue repair and rejuvenation. Emerging technologies such as exosome-based therapies and advanced tissue-engineering platforms exhibited significant innovation potential and may contribute to future therapeutic developments. Angiogenesis, extracellular matrix remodeling, cellular signaling, and endocrine regulation were identified as essential mechanisms underlying successful regenerative outcomes. Furthermore, the findings highlighted the increasing importance of personalized regenerative approaches that incorporate metabolic and hormonal optimization. Despite substantial progress, challenges related to protocol standardization, long-term clinical validation, regulatory frameworks, and accessibility remain significant barriers to widespread implementation. Overall, tissue bioengineering and regenerative aesthetic medicine represent promising strategies capable of transforming contemporary healthcare by promoting biological restoration, improving aesthetic outcomes, and advancing personalized therapeutic interventions.

30 June 2026 in IECCMEXICO
Verified
Journal Article
Open access
PDF file
JSJuan José Vergara Serpa
Juan José Vergara Serpa
MAMaría José Peñafiel Aguirre
María José Peñafiel Aguirre
JCJavier Emanuel Camacho-Patiño
Javier Emanuel Camacho-Patiño
VMVelbeth Elizabeth Recinos Martínez
Velbeth Elizabeth Recinos Martínez
ESElizabeth Parada Sánchez
Elizabeth Parada Sánchez
DQDiva Dalesska Herrería Quiñónez
Diva Dalesska Herrería Quiñónez
Chronic pruritus is a multifactorial clinical condition characterized by persistent itching and complex interactions among immune signaling, neuronal sensitization, psychological disturbances, and behavioral responses. Its clinical significance extends beyond cutaneous manifestations, frequently affecting sleep quality, emotional well-being, daily functioning, and overall quality of life. This narrative review aimed to analyze the neuroimmune mechanisms underlying chronic pruritus, examine its relationship with psychiatric comorbidities, and evaluate current multimodal therapeutic strategies from an international perspective, incorporating scientific contributions from Latin America. A qualitative, descriptive, and analytical approach was adopted to synthesize evidence from experimental investigations, observational studies, clinical trials, and international guidelines. The reviewed literature identified IL-4, IL-13, IL-31, and thymic stromal lymphopoietin as relevant mediators of neuroimmune communication, with signaling pathways involving JAK1, TRPV1, and TRPA1 contributing to sensory neuronal activation and hypersensitivity. Peripheral and central sensitization were associated with persistent sensory amplification and maintenance of the itch–scratch cycle. Psychiatric findings demonstrated clinically relevant associations with anxiety, depression, psychological stress, and sleep disturbances, although causal relationships remain incompletely established. Randomized clinical trials showed meaningful reductions in itch intensity following targeted inhibition of IL-4/IL-13 and IL-31 receptor signaling in patients with prurigo nodularis. Latin American evidence highlighted substantial symptom burden, quality-of-life impairment, and regional limitations in access to specialized healthcare. Overall, the findings support understanding chronic pruritus as a multidimensional condition requiring individualized assessment and coordinated dermatological, neurological, and psychological approaches. Further longitudinal and comparative investigations are necessary to clarify neuroimmune biomarkers, establish the clinical relevance of central sensitization, and determine the effectiveness of integrated multimodal interventions across different pruritic disorders.